Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -183,174 | -154,615 | -107,386 | -59,413 | -287,216 |
| Depreciation Amortization | 10,367 | 7,932 | 5,363 | 2,800 | 10,598 |
| Accounts receivable | -82,463 | -54,506 | -56,824 | -19,396 | -47,181 |
| Accounts payable and accrued liabilities | -6,460 | -17,770 | 19,631 | 13,662 | 31,318 |
| Other Working Capital | -23,058 | -15,697 | -24,480 | -10,149 | 33,478 |
| Other Operating Activity | 191,383 | 159,904 | 87,898 | 29,121 | 130,593 |
| Operating Cash Flow | $-93,405 | $-74,752 | $-75,798 | $-43,375 | $-128,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -480 | -409 | -351 | -338 | -270 |
| Investing Cash Flow | $-480 | $-409 | $-351 | $-338 | $-270 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 330,000 | 260,000 | 190,000 | N/A | N/A |
| Debt Repayment | -334,112 | -263,571 | -192,907 | -401 | -990 |
| Common Stock Issued | 127,462 | 106,449 | 80,979 | 36,685 | 71,464 |
| Other Financing Activity | -21,885 | -17,798 | -14,260 | -7,014 | -12,634 |
| Financing Cash Flow | $101,465 | $85,080 | $63,812 | $29,270 | $57,840 |
| Beginning Cash Position | 315,353 | 315,353 | 315,353 | 315,353 | 386,193 |
| End Cash Position | 322,933 | 325,272 | 303,016 | 300,910 | 315,353 |
| Net Cash Flow | $7,580 | $9,919 | $-12,337 | $-14,443 | $-70,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,405 | -74,752 | -75,798 | -43,375 | -128,410 |
| Capital Expenditure | -480 | -409 | -351 | -338 | -270 |
| Free Cash Flow | -93,885 | -75,161 | -76,149 | -43,713 | -128,680 |